The data presented in this manuscript suggests an interaction between the two pathways, as demonstrated by the enhanced protein levels of IGF-1R, p-IGF-1R, p-IRS-1, p-AKT and p-S6 in ovarian and breast cancer cells having loss-of-function mutations of BRCA1. This evidence concerns the gene BRCA1 and breast carcinoma.